Fabrication of nanomolecular platform based immunosensor for non-invasive electrochemical detection of oral cancer: An in vitro study

IF 4.1 Q1 CHEMISTRY, ANALYTICAL Talanta Open Pub Date : 2024-09-01 DOI:10.1016/j.talo.2024.100352
Meenakshi Choudhary , Vinay Kumar , Ashik Babu Parambath , Shruti Caplash , Birendra Kumar Yadav , Satbir Kaur , Sapna Ratan Shah , Kavita Arora
{"title":"Fabrication of nanomolecular platform based immunosensor for non-invasive electrochemical detection of oral cancer: An in vitro study","authors":"Meenakshi Choudhary ,&nbsp;Vinay Kumar ,&nbsp;Ashik Babu Parambath ,&nbsp;Shruti Caplash ,&nbsp;Birendra Kumar Yadav ,&nbsp;Satbir Kaur ,&nbsp;Sapna Ratan Shah ,&nbsp;Kavita Arora","doi":"10.1016/j.talo.2024.100352","DOIUrl":null,"url":null,"abstract":"<div><p>Silver nanoparticles (AgNPs)-Chitosan (Chi) functionalized cysteine (cys)-SAM (self-assembled monolayer) based electrochemical, label free, ultrasensitive, non-invasive immunosensing nanomolecular platform has been fabricated for the detection of novel OC biomarker S-100. This has been achieved through bio-functionalization of AgNPs-Chi/cys/mini gold slides by covalent immobilization of anti-S100 antibodies. Cyclic voltammetric (CV) studies establish successful fabrication of anti-S100/AgNPs-Chi/Au nanomolecular platform. Differential pulse voltammetric (DPV) measurements reveal that anti-S100/Chi-AgNPs/Au is able to sense 50 fg mL<sup>-1</sup> – 500 ng mL<sup>-1</sup> of S100 in buffer and in spiked saliva samples within 120 s interaction time having improved favorable shelf life and specificity. The fabricated platform is very selective and able to detect S100 in OC patient/s saliva samples warrants realization of simple non-invasive electrochemical immunosensor for <em>in situ</em> or <em>on-site</em> applications (especially for remote areas) for early diagnosis of OC while offering bio-compatibility at low cost.</p></div>","PeriodicalId":436,"journal":{"name":"Talanta Open","volume":"10 ","pages":"Article 100352"},"PeriodicalIF":4.1000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666831924000663/pdfft?md5=3345a9daaf0246157a50c3f630bbc45e&pid=1-s2.0-S2666831924000663-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Talanta Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666831924000663","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Silver nanoparticles (AgNPs)-Chitosan (Chi) functionalized cysteine (cys)-SAM (self-assembled monolayer) based electrochemical, label free, ultrasensitive, non-invasive immunosensing nanomolecular platform has been fabricated for the detection of novel OC biomarker S-100. This has been achieved through bio-functionalization of AgNPs-Chi/cys/mini gold slides by covalent immobilization of anti-S100 antibodies. Cyclic voltammetric (CV) studies establish successful fabrication of anti-S100/AgNPs-Chi/Au nanomolecular platform. Differential pulse voltammetric (DPV) measurements reveal that anti-S100/Chi-AgNPs/Au is able to sense 50 fg mL-1 – 500 ng mL-1 of S100 in buffer and in spiked saliva samples within 120 s interaction time having improved favorable shelf life and specificity. The fabricated platform is very selective and able to detect S100 in OC patient/s saliva samples warrants realization of simple non-invasive electrochemical immunosensor for in situ or on-site applications (especially for remote areas) for early diagnosis of OC while offering bio-compatibility at low cost.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于纳米分子平台的免疫传感器的制作,用于口腔癌的无创电化学检测:体外研究
为检测新型 OC 生物标志物 S-100,我们制作了基于银纳米粒子(AgNPs)-壳聚糖(Chi)-半胱氨酸(cys)-SAM(自组装单层)的电化学、无标记、超灵敏、非侵入性免疫传感纳米分子平台。这是通过共价固定抗 S100 抗体对 AgNPs-Chi/cys/mini 金片进行生物功能化实现的。循环伏安法(CV)研究证实了抗 S100/AgNPs-Chi/Au 纳米分子平台的成功制备。差分脉冲伏安法(DPV)测量结果表明,抗 S100/Chi-AgNPs/Au 能够在 120 秒的相互作用时间内感知缓冲液和加标唾液样品中 50 fg mL-1 - 500 ng mL-1 的 S100,并具有更好的保存期限和特异性。所制作的平台具有很高的选择性,能够检测 OC 患者/唾液样本中的 S100,因此可以实现简单的无创电化学免疫传感器,用于原位或现场应用(尤其是偏远地区),对 OC 进行早期诊断,同时具有低成本的生物兼容性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Talanta Open
Talanta Open Chemistry-Analytical Chemistry
CiteScore
5.20
自引率
0.00%
发文量
86
审稿时长
49 days
期刊最新文献
Continuous-flow analysis of nitrogen compounds in environmental water using a copper–zinc reduction coil Development of engineered Zn-MOF/g-C3N4 based photoelectrochemical system for real-time sensors and removal of naproxen in wastewater Development of nanomaterial-supported molecularly imprinted polymer/receptor-like sensor for the detection of rosuvastatin from binary mixtures Trace-level quantification of NDMA in levosulpuride active pharmaceutical ingredient and tablet formulation Using UFLC-MS/MS Enhancing isomer specificity in mass spectrometry by combining silver ion adduction and ion mobility
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1